Chris Turner
-
- Genetic Neurodegenerative Diseases 13
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 9
-
- Genetics, Aging, and Longevity in Model Organisms 3
-
- Muscle Physiology and Disorders 7
- Mitochondrial Function and Pathology 3
- Genomics, phytochemicals, and oxidative stress 2
-
- Circadian rhythm and melatonin 3
-
- Trauma Management and Diagnosis 2
Chris Turner
38 papers receiving 658 citations
Peers
Comparison fields: 5 of 135
- Cellular and Molecular Neuroscience 221
- Neurology 168
- Critical Care and Intensive Care Medicine 53
- Aging 12
- Public Administration 15
Countries citing papers authored by Chris Turner
This map shows the geographic impact of Chris Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Turner more than expected).
Fields of papers citing papers by Chris Turner
This network shows the impact of papers produced by Chris Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Turner. The network helps show where Chris Turner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chris Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 0 | |
| 5 | Strategy in Uncertain Times: Lenses to Approach Decision Making, Forecasting, and Planning | 2021 | 0 |
| 6 | 2021 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 22 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 9 | |
| 13 | 2017 | 21 | |
| 14 | 2014 | 0 | |
| 15 | 2014 | 124 | |
| 16 | 2013 | 2 | |
| 17 | 2003 | 5 | |
| 18 | 2003 | 6 | |
| 19 | 2003 | 3 | |
| 20 | 2002 | 22 |
About Chris Turner
Chris Turner is a scholar working on Aging, Neurology, Cellular and Molecular Neuroscience, Health Informatics and General Dentistry, having authored 48 papers that have together received 701 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (13 papers), Parkinson's Disease Mechanisms and Treatments (9 papers), Muscle Physiology and Disorders (7 papers), Mitochondrial Function and Pathology (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers), Circadian rhythm and melatonin (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Trauma Management and Diagnosis (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (221 citations), Neurology (168 citations), Critical Care and Intensive Care Medicine (53 citations), Aging (12 citations) and Public Administration (15 citations). Chris Turner has collaborated with scholars based in United Kingdom, Canada and Germany. Frequent co-authors include David Hilton‐Jones, André Gorz, Chris Tilly, D. James Morré, Hanns Lochmüller, Carole L. Jelsema, Manfred Ruddat, Jeff Boyd, Cecilia Jimenez‐Moreno and Nikoletta Nikolenko. Their work appears in journals such as Canadian Journal of Emergency Medicine, Journal of Neurology, Muscle & Nerve, Neuromuscular Disorders and Cardiovascular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.